Top Story
Congress Votes to Override Veto on Medicare Bill
On July 15, 2008, Congress rejected President Bush's veto of legislation protecting doctors from a 10.6% cut in their reimbursement rates when treating Medicare patients.
News
Lakewood Pathology Associates Changes Name to PLUS Diagnostics
Lakewood Pathology Associates announced that it will adopt a new name, PLUS Diagnostics, an acronym for Pathology Laboratory of the United States,.
AdvanDx Test Slashes ICU Mortality Rates from S. Aureus, Study Shows
AdvanDx, Woburn, Mass, reports that use of its PNA FISH test was associated with an 82% reduction in mortality rates from S. aureus bloodstream infections in the intensive care unit (ICU), a 53% reduction in overall mortality from staphylococcal bloodstream infections, and a significant reduction in antibiotic use.
American Diagnostica Acquires vWF Activity Kit
American Diagnostica Inc. announced it has acquired the manufacturing rights to the Axis-Shield von Willebrand Factor (vWF) Activity Kit.
Now Available
LabCorp Announces Availability of ColoSure TM
LabCorp is now offering ColoSure(TM), among the most sensitive, in-guideline non-invasive colorectal cancer screening methods available.
Product News
Fisher Scientific Launches ABsolute Fast QPCR Master Mixes
Thermo Fisher Scientific Inc. announced the launch of ABsolute Fast QPCR Master Mixes.
Expanded Capabilities for Development of Data Management Solutions
Labtronics Inc. announced a new release of the Nexxis Application Development Platform.
People
Alverix Appoints James D. Merselis President And CEO
Alverix, Inc., an optoelectronics company developing portable medical diagnostic instruments in cooperation with leading point-of-care (POC) diagnostics companies, announced the appointment of James D. Merselis as President and Chief Executive Officer.
Financings
Pacific Biosciences Raise $100 Million
Pacific Biosciences announced that it raised $100 million in funding for commercial development of its high speed DNA sequencing platform
Research & Development
Power 3 and Jordan Organizations Collaborate on Breast Cancer Diagnostic
Power 3 Medical Products announced a collaboration with the Princess Haya Biotechnology Center and the Jordan University of Science and Technology.
Gene Variations Determine Response to Antidepressant
Mayo Clinic study shows that variations in the serotonin transporter gene could explain why some people with depression respond better than others to treatment with citalopram (Celexa.
|
